EDGAR Filing Documents for 0001179110-08-012730

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001179110-08-012730

Filing Date

2008-06-25

Accepted

2008-06-25 15:36:00

Documents

Period of Report

2008-06-24

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 -	edgar.html	4
1	FORM 4 -	edgar.xml	4	3800
	Complete submission text file	0001179110-08-012730.txt		5758

Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114

Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062817001

PONIARD PHARMACEUTICALS, INC. (Issuer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114

Business Address 206-281-7001

Type: 4 | Act: 34 | File No.: 000-16614 | Film No.: 08916673